Journey Medical Surges with Amrozi Growth | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded20 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20070904

Show notes

Journey Medical’s Q2 earnings soar with Amrozi leading the charge, raking in $8.1M—up sharply thanks to more doctors prescribing it and better insurance coverage. New sales hires and record prescription numbers (5,300+ in June) signal explosive growth, with over 4,500 dermatologists now on board. Their new anti-itch cream, Urox, is gaining early traction. Total revenue jumped 23% YoY to $18.5M, net loss narrowed, and cash reserves hit $25M—signaling a path to profitability. Next up: expanding payer access, exploring global licensing, and adding new dermatology assets—all pointing to a breakout 2026. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3cd70945b2ca1730

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.